As the number of coronavirus cases continues to rise in the U.S., Johnson & Johnson's chief scientific officer Dr. Paul Stoffels told Cheddar the company has an accelerated plan to create a vaccine.
"At the moment, we predict that we can get north of one billion vaccine dosages in the course of 2021 and even much more afterward," he said.
The company is currently running clinical trials on animals and expects to move to human testing in late July. Stoffels describes the project as a "massive amount of parallel work" that was jumpstarted by a federal investment of $456 million.
Typically, developing a vaccine calls for one to three years of successful testing, but Johnson & Johnson expects to have an approved vaccine by early 2021. One challenge the company will face is locating a pocket of study subjects — between 30,000 and 100,000 people — that have potentially been exposed. The large study size is key for the pharmaceutical giant to meet its self-imposed timeline.
"The higher the transmission rate, the faster we can see the endpoint and we can prove efficacy," Stoffels told Cheddar.
The pharmaceutical giant's confidence in distributing the vaccine by early next year also lies in cell line technology, which has the capacity to create a massive number of doses.
"In a thousand-liter vessel, we can produce more than 150 million vaccines a year," he said.
Stoffels also keyed in on the need for urgency and additional preventative steps the world should take in light of the disease still sweeping the globe.
"Nobody expected such a pandemic happening," he said. "We have learned that we have to have much more public health measures in the world."
Former Cisco Systems CEO John Chambers learned all about technology’s volatile highs and lows as a veteran of the internet’s early boom days during the late 1990s and the ensuing meltdown that followed the mania. And now he is seeing potential signs of the cycle repeating with another transformative technology in artificial intelligence. Chambers is trying take some of the lessons he learned while riding a wave that turned Cisco into the world's most valuable company in 2000 before a crash hammered its stock price and apply them as an investor in AI startups. He recently discussed AI's promise and perils during an interview with The Associated Press.
Grove Collaborative’s CEO shares how the company is reinventing everyday goods with sustainability at the core and working toward a plastic-free future.
Atlanta Mayor Andre Dickens shares plans for affordable housing, community-led growth, and why private and public grocery stores could be key to food equity.
Tesla reported a surprise increase in sales in the third quarter as the electric car maker likely benefited from a rush by consumers to take advantage of a $7,500 credit before it expired on Sept. 30. The company reported Thursday that sales in the three months through September rose 7% compared to the same period a year ago. The gain follows two quarters of steep declines as people turned off by CEO Elon Musk’s foray into right-wing politics avoided buying his company’s cars and even protested at some dealerships. Sales rose to 497,099 vehicles, compared with 462,890 in the same period last year.
